Monto AS Posted by By eagulf September 2, 2022Posted inNucleoside Transporters Monto AS. 2006. generated more cross-neutralizing antibodies and higher levels of serum antibody binding to HA1, with stronger avidity and a better IgG/IgM ratio, than monomeric HA1 and SU-H5N1 vaccines,…